Table 3 Principal biochemical characteristics of our cohort at pre-Ktx evaluation at T0 and during the period T0–T5.
Parameters | Pre-KTx examination | T0 | Average T0–T5 | p* |
|---|---|---|---|---|
SBP (mmHg) | NA | 135 [120–150] | 135 [124–143] | 0.24 |
DBP ((mmHg) | NA | 80 [80–90] | 82 [77–85] | 0.35 |
s-Creatinine (mg/dL) | 8.0 [5.6–11.0] | 1.41 [1.1–1.7] | 1.5 [1.2–1.7] | 0.09 |
Blood glucose (mg/dL) | 91 [82–101] | 74 [67–87] | 79 [75–86] | 0.009 |
Hb (g/dl) | 11.3 [10.3–12.5] | 10.8 [10–12] | 12 [11–13] | <0.0001 |
PTH (ng/mL) | 249 [148–470] | 150 [94–217] | 111 [80–179] | 0.01 |
Ca (mg/dl) | 9.2 [8.8–9.6] | 9.8 [9–10] | 9.8 [9.5–10.2] | 0.28 |
P (mg/dL) | 5.2 [4.3–5.7] | 2.3 [2–2.8] | 3 [2.7–3.4] | <0.0001 |
ALP (U/dL) | 106 [62–171] | 91 [68–114] | 64 [54–78] | 0.01 |
Prot-U (g/24 h) | NA | 0.21 [0.15–0.33] | 0.19 [0.15–0.32] | 0.74 |
Total Cholesterol (mg/dl) | NA | 226 [198–254] | 211 [185–233] | <0.0001 |
HDL Cholesterol (mg/dl) | NA | 61 [49–73] | 57 [50–71] | 0.004 |
Triglycerides (mg/dl) | NA | 158 [119–209] | 145 [118–191] | <0.0001 |
